Statins and PCSK9 Regulation
Author Information
Author(s): Duddu Sushmitha, Katakia Yash T., Chakrabarti Rituparna, Sharma Pooja, Shukla Praphulla Chandra
Primary Institution: Indian Institute of Technology Kharagpur
Hypothesis
Statins modulate the expression of PCSK9 through epigenetic regulation involving histone modifications.
Conclusion
Statins increase PCSK9 expression by enhancing histone methylation and acetylation, which can be reversed by specific inhibitors.
Supporting Evidence
- Statins increase the expression of PCSK9 by regulating the expression of SREBP2.
- Treatment with atorvastatin significantly upregulated both transcript and protein levels of PCSK9.
- Pharmacological inhibition of histone marks reversed the statin-induced upregulation of PCSK9.
- Combination of statins with specific inhibitors improved LDL uptake in hepatocytes.
Takeaway
Statins help lower bad cholesterol but can also raise a protein called PCSK9 that makes it harder to do so; this study found ways to reduce PCSK9 levels.
Methodology
The study involved in vitro experiments with HepG2 cells and in vivo experiments with mice to assess the effects of atorvastatin on PCSK9 expression and histone modifications.
Potential Biases
Potential bias in the interpretation of results due to reliance on specific animal models and cell lines.
Limitations
The study primarily focused on in vitro and animal models, limiting direct applicability to human patients.
Participant Demographics
Male C57BL6 mice aged 6-8 weeks were used in the study.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website